SQSTM1 and breast cancer: Then, Western blot analysis was conducted to determine whether MA affects autophagy in breast cancer cells, and the findings showed that MA dose-dependently elevated the levels of autophagic substrate p62/SQSTM1 and autophagosome marker LC3-II.